-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Kasai Bio, which was listed in mid-August, broke on the 4th day of its listing, and it "falls endlessly"
.
This year will be the warmest on record
.
"Cashmere sweater from corn"
"Cashmere sweater from corn"Speaking of Kasai Bio, I have to mention the founder Dr.
Liu Xiucai
.
In the 1990s, after completing postdoctoral research at Columbia University and Yale University, Liu Xiucai was hired by the Santos Institute of Pharmacy with a high salary to be in charge of a new drug design department
.
Two or three years after the establishment of Cathay Biotech, Liu Xiucai led the R&D team to solve the problem of purification of long-chain dibasic acids, which made the production cost of long-chain dibasic acids in biological methods drop significantly compared with chemical methods.
The international market share in the field has reached 90%
.
In 2006, Kasai Bio began to develop pentamethylenediamine monomers and bio-based polyamide polymers using corn as raw materials.
In 2014, it completed a thousand-ton pilot test, and in 2016, it completed a 5,000-ton production line.
In 2018, in Wusu, Xinjiang The trial production of the 100,000-ton production line was successful
.
New material promotion meets resistance
New material promotion meets resistanceLong-chain dibasic acid is a monomer, and there are similar chemicals, so there is no obstacle in sales.
However, after the successful development of bio-based polyamide, Kasai Bio needs to overcome the problem of market access in the sales process
.
In 2015, Cathay Biotech teamed up with Covestro to use pentamethylenediamine to make the outermost varnish for automobiles.
The varnish coating made of pentamethylenediamine can be thinner and more scratch-resistant
.
Clothing is the earliest market developed by Kasai Bio
.
In terms of technology, bio-based polyamide is spun into silk, woven into cloth, and dyed and finished into fabric
.
When Kasai Bio began to sell to spinning mills, no one wanted to try it.
After working with the apparel giant, spinning mills were willing to use it, but they encountered technical problems
.
As a result, Kasai Bio introduced the backbone of the team from large international companies to study new product spinning, printing and dyeing processes, and invited textile experts that could be invited to study the spinning process for six or seven years, and established a printing and finishing laboratory.
The development process of various dyes and conditions of use has solved many common-sense problems in the textile, printing and dyeing industry, and helped downstream textile, printing and dyeing to adjust the process parameters, so that they can use bio-based polyamide for spinning, dyeing and finishing and the use of "nylon 66" non-woven fabrics.
different
.
Liu Xiucai, chairman of Cathay Biosciences, said, "If you don't study new materials, others will not do it for you
.
" This year, Kasai Bio's efforts in this area will usher in a harvest, and the cooperation with the State Sports General Administration and international top sports brands will likely be officially launched
.
After being made into plastic parts based on bio-based polyamide, it is wear-resistant, creep-resistant, spray-free, and has high strength and good thermal insulation
.
At present, Kasai Bio is also expanding the application of bio-based polyamides in automobiles, electronic appliances, rail transit and daily consumer goods
.
The technical team builds the shape
The technical team builds the shapeAfter addressing downstream demand, the expansion of production capacity will bring profit growth
.
According to Kasai Bio's prospectus, the company is building or planning to implement a number of capacity expansion projects.
After the above projects are completed and put into operation, the company's product line and production capacity will expand significantly, and the company's total product production capacity will reach 75,000 tons.
Dibasic acid, 40,000 tons of bio-process sebacic acid, 50,000 tons of bio-based pentamethylene diamine, 100,000 tons of general-purpose polyamide, and 20,000 tons of high-performance long-chain polyamide
.
Biomanufacturing, in technical terms, the production of products by means of synthetic biology, is gaining increasing attention
.
The big era of biomaterial application is coming, and small trees are in sight
.
The global leader - Kasai Bio has made full preparations.
The R&D team has grown from 7 people to 100 people at the beginning, and has built four major fields ranging from genetic engineering, bioengineering, biochemical engineering to the polymerization and modification of biopolymer materials.
The core technology platform has established a R&D and industrialization construction team with superb technology and rich experience
.
At present, the company has many patents and non-patented technologies in the field of bio-manufacturing
.
Liu Xiucai said that Kasai Bio is mainly doing two things at present.
One is to conduct applied research on the two bio-based materials that have been developed to create new applications and realize large-scale production; the other is to develop new bio-based materials
.
He believes that with the successful development of two bio-based materials, new bio-based materials can be developed in the future
.
Looking to the future, Liu Xiucai has the usual rigor of scientists
.
He said that Kasai Bio is engaged in green manufacturing that is needed all over the world.
The mainstream industry will come out sooner or later.
Their success is just an example.
At present, it seems that they have achieved technological leadership and become the first to make money, but competitors will definitely appear.
, Cathay Biosciences should make fewer mistakes and keep the technology ahead
.
